Kate was a tireless advocate for cancer research. May her memory be a blessing.
http://fightcolorectalcancer.org/resear ... more-17045KATE MURPHY: A Life Lived Well
Posted by Mary Miller on October 3rd, 2012
… Cancer has enriched my life. I look forward to each day with its special joys and new possibilities. I have learned to live completely and fully. And I hate to leave this life behind now that I’ve found it. – Kate Murphy, 1997.
(The full message and a poem written by Kate follow at the end of this post.)
The light dimmed a little today in the world of cancer research and patient advocacy. With deep grief but also gratitude for her life’s work, we report the passing of Kate Murphy, age 70, today (Oct. 3). While living 29 years with multiple Lynch-associated cancers and multiple sclerosis, she became one of the most respected patient advocates in the nation.
Kate was rare: She could knowledgably discuss cell-level biochemical pathways with world-renowned scientists; spin out concise, accurate reports all day long at a national oncology conference; and then, late at night in her hotel room, log onto an online cancer group and reassure a frightened, newly diagnosed patient with a blazingly clear summary of what steps should come next.
Diagnosed with her first (colon) cancer in 1983, Kate got her first modem in 1995 and within a month of its founding, joined the ACOR (Association of Cancer Online Resource) colorectal cancer group. In recent years she became the “list mom,” monitoring and frequently dipping into the online chats with carefully scientific yet compassionate explanations of everything from new drugs to complementary medicine to day-to-day symptom survival tips.
Kate was in the first group of Colon List members who joined forces to found the Colon Cancer Alliance in 1999, and in 2005 she was on the founding team of Fight Colorectal Cancer, where she worked as Director of Research Communications right up until her death. She often said, “Knowledge can break the desperate cycle of helplessness and hopelessness” for patients and families.
She didn’t just bring knowledge to patients; she took the patients’ perspective back to the professional and scientific community. She served on many scientific committees which reviewed grant proposals, monitored patient safety and developed clinical trial concepts (a partial list of her affiliations follows this article). Her work with these committees was deeply respected by both patients and experts.
(use the link to read more)